<DOC>
	<DOCNO>NCT00000178</DOCNO>
	<brief_summary>This randomize placebo control , double blind study . Patients meet eligibility criterion decide participate study randomly assign receive either drug treatment placebo . Neither patient participate investigator know receive drug receive placebo . Participation involve 15 outpatient clinic visit 68 week period . Patients take study medication vary dos ( maximum dose 20 mg daily ) , along calcium vitamin supplement .</brief_summary>
	<brief_title>Multicenter Trial Prednisone Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>Patients Alzheimer 's disease stable medical condition Patients diabetes severe osteoporosis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2005</verification_date>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>Prednisone</keyword>
	<keyword>Anti-inflammatory agent</keyword>
</DOC>